Study Purpose
Our goal is to construct a national registry of patients with chronic thromboembolic pulmonary hypertension (CTEPH) to inform a nationwide prospective survey to investigate the efficacy and safety of different treatments for the disease. We seek to optimize how the disease is treated and improve how affected patients are handled in clinical practice by creating evidence based on the registry data to guide the selection of therapeutic strategies on a strong empirical basis.
NEWS
- 2024.08.06Study News The CTEPH AC Registry has reached 1,684 registered patients!
- 2024.05.29Announcement Just accepted in the JACC: Asia. Second report from CTEPH AC Registry
- 2024.02.13Study News The CTEPH AC Registry has reached 1,549 registered patients!
- 2023.11.06Study News The CTEPH AC Registry has reached 1,393 registered patients!
- 2023.07.11Announcement The CTEPH AC Registry has reached 1,266 registered patients!
- 2023.04.28Announcement The first report on the CTEPH AC registry was published in the Journal of thrombosis and haemostasis.
Participating Institutions and Registered CasesFACILITY
Please click on the map to see institutions in each area.